查詢結果分析
來源資料
相關文獻
- 第一期下期與第二期上期之子宮頸癌經不同治療模式後的長期生活品質比較
- 早期子宮頸癌病患治療後長期的生活品質之研究
- Implications of a Failed Prospective Trial of Adjuvant Therapy after Radical Hysterectomy for Stage Ib-IIa Cervical Carcinoma with Pelvic Node Metastases
- 放射治療後長期存活之鼻咽癌病人的生活品質調查
- Results of Postoperative Radiotherapy for Clinical Stage Ib Uterine Cervical Carcinoma with Evidence of Microscopic Involvement of Surgical Margin, Parametrium and/or Lymph Node Metastasis
- 子宮頸癌之術後放射治療
- 子宮頸癌中拓樸酵素I活性的升高與喜樹鹼增強放射治療的展現
- A Phase Ⅱ Trial of Concurrent Chemoradiation with Weekly Cisplatin and Glutathione for Bulky Advanced Cervical Cancer
- 子宮頸癌的預後因素及化學治療在子宮頸癌治療的角色
- 非外科治療晚期子宮頸癌
頁籤選單縮合
題 名 | 第一期下期與第二期上期之子宮頸癌經不同治療模式後的長期生活品質比較=Comparison of Long-Term Quality of Life for Patients with Stage IB-ⅡA Uterine Cervical Carcinoma Treated with Different Modalities |
---|---|
作 者 | 許維中; 詹淑卿; 鍾娜娜; 陳宇嘉; 丁禮莉; 陳斯榮; 蔡崇煌; 王博民; 謝保群; 林高德; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 12:3 民94.09 |
頁 次 | 頁181-189 |
分類號 | 417.2832 |
關鍵詞 | 生活品質; 放射治療; 子宮頸癌; EORTC; Quality of life; Radiotherapy; Uterine cervical cancer; |
語 文 | 中文(Chinese) |
中文摘要 | 目的:本研究之目的是比較以不同的治療方式,對第一期下期或第二期上期子宮頸癌病患長期的副作用與生活品質之差異。 材料與方法:總共有兩機構的336位第一期下期或第二期上期子宮頸癌病患被邀請參與研究。病患均在治療結速後兩年以上(介於25至218個月),選擇45-74歲的261位中、老年為研究對象。依治療方式之不同區分為手術治療、放射治療與術後放射治療三組。病患須填寫EORTC QLQ C-30生活品質量表及子宮頸癌治療後的副作用量表,並以此作為生活品質評估之依據。 結果:共有八項副作用在統計上達到顯著差異,包括:腹痛、腹瀉、便祕、血便、排尿困難、尿失禁、下肢水腫及臉潮紅。其中,手術組於便祕、排尿困難及臉潮紅之副作用明顯高於其他兩組,放療組於腹瀉及血便兩項顯著較高,術後放療組則有較高的腹瀉、血便、尿失禁及下肢水腫之副作用。以EORTIC QLQ-C30生活品質來比較,除了功能性尺度上的認知功能和社會功能兩項,以及症狀尺度之疲倦、噁心/嘔吐、食慾不振、便祕和經濟困難五項達到統計上的顯著水準外,其餘多項生活品質指標於三組間差異不大,均未達顯著意義。 結論:本研究顯示第一期下期或第二期上期子宮頸癌病患接受不同治療模式的副作用有所不同,但長期之整體生活品質差異不大。本文有助於臨床醫師考量病患接受治療後之生活品質的改變,也可對病患治療後的復健與支持照護上所幫助。 |
英文摘要 | Purpose: To analyze treatment results and prognostic factors of esthesioneuroblastoma (ENB). Materials and methods: Twenty-one patients with diagnosis of ENB treated between 1989 and 2004 were reviewed. There were 14 men and 7 women. Patients’ age ranged fro 17 to 88. Presenting symptoms/signs, tumor extent, treatment modalities, survival time, and disease-free survival time were recorded. Ten patients (48%) were treated with conventional two-dimensional technique and 11 (52%) with three-dimensional conformal radiotherapy (3D-CRT). Patient’s performance status was scored with Karnofsky performance scale (KPS). Tumor extent was staged using Kadish system. Results: Of the 21 patients, 2 were Stage A, 3 Stage B, and 16 Stage C. After a mea follow-up time of 35 months, 4 patients are alive with disease and 4 are alive without disease. Locoregional failure occurred in 6 patients and distant metastases were noted in 5patients. Of the 15 initially node-negative patients who did not receive elective neck irradiation, 3 (20%) failed in the neck. Five-year overall survival rate was 42% and 5-year disease free survival rate was 17%. In univariate analysis, age (≦60 vs.> 60) and KPS (≧80 vs. <80) were significant prognostic factors for overall survival (p=0.019, p=0.000, respectively) and disease-free survival (p=0.021, p=0.001, respectively). Conclusion: Treatment results in our series are compatible with others. We find that age and KPS are significant prognostic factors in predicting the outcome. Due to relatively high incidence of neck failure, elective neck irradiation seems worthy to be considered in selective patients. |
本系統中英文摘要資訊取自各篇刊載內容。